{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T02:19:03Z","timestamp":1784081943078,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T00:00:00Z","timestamp":1698105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.14283\/jpad.2023.107","type":"journal-article","created":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T12:25:59Z","timestamp":1698150359000},"page":"669-674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["ASURE Clinical Trial Protocol: A Randomized, Placebo-Controlled, Proof-of-Concept Study Aiming to Evaluate Safety and Target Engagement following Administration of TW001 in Early Alzheimer's Disease Patients"],"prefix":"10.1016","volume":"10","author":[{"given":"Marlies","family":"Oosthoek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"van Loosbroek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"van der Geest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"de Greef-van der Sandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"van Bokhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.A.M.","family":"Sikkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.E.","family":"Teunissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.G.B.","family":"Vijverberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.14283\/jpad.2023.107_bib1","unstructured":"Organization, W. h. Global action plan on the public health response to dementia, 2017."},{"key":"10.14283\/jpad.2023.107_bib2","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer's disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"10.14283\/jpad.2023.107_bib3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer's & Dementia"},{"key":"10.14283\/jpad.2023.107_bib4","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41598-023-27420-x","article-title":"Single-cell-led drug repurposing for Alzheimer's disease","volume":"13","author":"Parolo","year":"2023","journal-title":"Scientific Reports"},{"key":"10.14283\/jpad.2023.107_bib5","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3233\/JAD-161088","article-title":"Oxidative Stress, Synaptic Dysfunction, and Alzheimer's Disease","volume":"57","author":"T\u00f6nnies","year":"2017","journal-title":"Journal of Alzheimer's Disease"},{"key":"10.14283\/jpad.2023.107_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1471-4159.2008.05347.x","article-title":"Amyloid beta peptide and NMDA induce ROS from NADPH oxidase and AA release from cytosolic phospholipase A2 in cortical neurons","volume":"106","author":"Shelat","year":"2008","journal-title":"Journal of Neurochemistry"},{"key":"10.14283\/jpad.2023.107_bib7","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.redox.2017.10.014","article-title":"Oxidative stress and the amyloid beta peptide in Alzheimer's disease","volume":"14","author":"Cheignon","year":"2018","journal-title":"Redox Biology"},{"key":"10.14283\/jpad.2023.107_bib8","first-page":"795375","article-title":"Amyloid beta: multiple mechanisms of toxicity and only some protective effects?","author":"Carrillo-Mora","year":"2014","journal-title":"Oxid Med Cell Longev"},{"key":"10.14283\/jpad.2023.107_bib9","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S1471-4914(01)02173-6","article-title":"Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide","volume":"7","author":"Butterfield","year":"2001","journal-title":"Trends Mol Med"},{"key":"10.14283\/jpad.2023.107_bib10","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1179\/1351000213Y.0000000052","article-title":"Oxidative stress in Alzheimer's disease: Primary villain or physiological by-product?","volume":"18","author":"Sutherland","year":"2013","journal-title":"Redox Report"},{"key":"10.14283\/jpad.2023.107_bib11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.neulet.2009.11.010","article-title":"Chronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells","volume":"468","author":"Su","year":"2010","journal-title":"Neuroscience Letters"},{"key":"10.14283\/jpad.2023.107_bib12","doi-asserted-by":"crossref","first-page":"101619","DOI":"10.1016\/j.arr.2022.101619","article-title":"Oxidative stress: The core pathogenesis and mechanism of Alzheimer's disease","volume":"77","author":"Bai","year":"2022","journal-title":"Ageing Research Reviews"},{"key":"10.14283\/jpad.2023.107_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3233\/JAD-180583","article-title":"Positive Feedback Loops in Alzheimer's Disease: The Alzheimer's Feedback Hypothesis","volume":"66","author":"Doig","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.14283\/jpad.2023.107_bib14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/13510002.1996.11747069","article-title":"Antioxidant activity of 3-methyl-1-phenyl-2-pyrazolin-5-one","volume":"2","author":"Yamamoto","year":"1996","journal-title":"Redox Rep"},{"key":"10.14283\/jpad.2023.107_bib15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3164\/jcbn.17-62","article-title":"How is edaravone effective against acute ischemic stroke and amyotrophic lateral sclerosis?","volume":"62","author":"Watanabe","year":"2018","journal-title":"J Clin Biochem Nutr"},{"key":"10.14283\/jpad.2023.107_bib16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1179\/1351000215Y.0000000025","article-title":"Edaravone, a potent free radical scavenger, reacts with peroxynitrite to produce predominantly 4-NO-edaravone","volume":"21","author":"Fujisawa","year":"2016","journal-title":"Redox Rep"},{"key":"10.14283\/jpad.2023.107_bib17","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1021\/jp209930y","article-title":"On the Outstanding Antioxidant Capacity of Edaravone Derivatives through Single Electron Transfer Reactions","volume":"116","author":"P\u00e9rez-Gonz\u00e1lez","year":"2012","journal-title":"The Journal of Physical Chemistry B"},{"key":"10.14283\/jpad.2023.107_bib18","doi-asserted-by":"crossref","first-page":"10375","DOI":"10.1021\/jp2047163","article-title":"Ionization energies, proton affinities, and pKa values of a large series of edaravone derivatives: implication for their free radical scavenging activity","volume":"115","author":"P\u00e9rez-Gonz\u00e1lez","year":"2011","journal-title":"J Phys Chem B"},{"key":"10.14283\/jpad.2023.107_bib19","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1073\/pnas.1422998112","article-title":"Edaravone alleviates Alzheimer's disease-type pathologies and cognitive deficits","volume":"112","author":"Jiao","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.14283\/jpad.2023.107_bib20","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neulet.2012.10.043","article-title":"Protective effect of edaravone against Alzheimer's disease-relevant insults in neuroblastoma N2a cells","volume":"531","author":"Yan","year":"2012","journal-title":"Neurosci Lett"},{"key":"10.14283\/jpad.2023.107_bib21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.lfs.2019.02.025","article-title":"Edaravone reduces A\u03b2-induced oxidative damage in SH-SY5Y cells by activating the Nrf2\/ARE signaling pathway","volume":"221","author":"Zhang","year":"2019","journal-title":"Life Sci"},{"key":"10.14283\/jpad.2023.107_bib22","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.2147\/DDDT.S161944","article-title":"Self-nanomicellizing solid dispersion of edaravone: part II: in vivo assessment of efficacy against behavior deficits and safety in Alzheimer's disease model","volume":"12","author":"Parikh","year":"2018","journal-title":"Drug Des Devel Ther"},{"key":"10.14283\/jpad.2023.107_bib23","doi-asserted-by":"crossref","first-page":"e12020","DOI":"10.1002\/trc2.12020","article-title":"The Cognitive-Functional Composite is sensitive to clinical progression in early dementia: Longitudinal findings from the Catch-Cog study cohort","volume":"6","author":"Jutten","year":"2020","journal-title":"Alzheimer's & Dementia: Translational Research & Clinical Interventions"},{"key":"10.14283\/jpad.2023.107_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cccn.2003.09.010","article-title":"Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics","volume":"339","author":"Wu","year":"2004","journal-title":"Clinica Chimica Acta"},{"key":"10.14283\/jpad.2023.107_bib25","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1001\/archneur.59.5.794","article-title":"Lymphocyte Oxidative DNA Damage and Plasma Antioxidants in Alzheimer Disease","volume":"59","author":"Mecocci","year":"2002","journal-title":"Archives of Neurology"},{"key":"10.14283\/jpad.2023.107_bib26","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/jnr.10349","article-title":"Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer's disease","volume":"70","author":"Abe","year":"2002","journal-title":"Journal of Neuroscience Research"},{"key":"10.14283\/jpad.2023.107_bib27","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.brainres.2007.02.084","article-title":"Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: Implications for the role of nitration in the progression of Alzheimer's disease","volume":"1148","author":"Butterfield","year":"2007","journal-title":"Brain Research"},{"key":"10.14283\/jpad.2023.107_bib28","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.trci.2017.01.004","article-title":"A composite measure of cognitive and functional progression in Alzheimer's disease: Design of the Capturing Changes in Cognition study","volume":"3","author":"Jutten","year":"2017","journal-title":"Alzheimer's & Dementia: Translational Research & Clinical Interventions"},{"key":"10.14283\/jpad.2023.107_bib29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.dadm.2017.03.002","article-title":"Detecting functional decline from normal aging to dementia: Development and validation of a short version of the Amsterdam IADL Questionnaire","volume":"8","author":"Jutten","year":"2017","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.14283\/jpad.2023.107_bib30","first-page":"e12452","article-title":"Cross-sectional and longitudinal assessments of function in prodromal-to-mild Alzheimer's disease: A comparison of the ADCS-ADL and A-IADL-Q scales","volume":"15","author":"Teng","year":"2023","journal-title":"Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"10.14283\/jpad.2023.107_bib31","first-page":"e12021","article-title":"The influence of diversity on the measurement of functional impairment: An international validation of the Amsterdam IADL Questionnaire in eight countries","volume":"12","author":"Dubbelman","year":"2020","journal-title":"Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"10.14283\/jpad.2023.107_bib32","doi-asserted-by":"crossref","first-page":"e954","DOI":"10.1212\/WNL.0000000000200781","article-title":"Determining the Minimal Important Change of Everyday Functioning in Dementia: Pursuing Clinical Meaningfulness","volume":"99","author":"Dubbelman","year":"2022","journal-title":"Neurology"},{"key":"10.14283\/jpad.2023.107_bib33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13195-019-0500-5","article-title":"Assessing cognition and daily function in early dementia using the cognitive-functional composite: findings from the Catch-Cog study cohort","volume":"11","author":"Jutten","year":"2019","journal-title":"Alzheimer's Research & Therapy"},{"key":"10.14283\/jpad.2023.107_bib34","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1161\/01.STR.0000182241.07096.06","article-title":"Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain","volume":"36","author":"Zhang","year":"2005","journal-title":"Stroke"},{"key":"10.14283\/jpad.2023.107_bib35","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/17482960600881870","article-title":"Investigation of the therapeutic effects of edaravone, a free radical scavenger, on amyotrophic lateral sclerosis (Phase II study)","volume":"7","author":"Yoshino","year":"2006","journal-title":"Amyotrophic Lateral Sclerosis"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724001559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724001559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T02:09:33Z","timestamp":1737338973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724001559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":35,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2274580724001559"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2023.107","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ASURE Clinical Trial Protocol: A Randomized, Placebo-Controlled, Proof-of-Concept Study Aiming to Evaluate Safety and Target Engagement following Administration of TW001 in Early Alzheimer's Disease Patients","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2023.107","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}